A clinical trial to to study the effect of sukshmaeladi choorna in patients with high cholesterol levels

A randomized controlled clinical study to evaluate the effect of Sookshma Eladi choornam in Hyperlipidaemias - RASH

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/07/020460

Enrollment

Registered

2019-07-31

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E785- Hyperlipidemia, unspecified

Interventions

Intervention1: Sukshma eladi choornam Atorvastatin : Sukshma eladi choornam 3 grams twice orally for 3 months Atorvastatin orally for 3 months

Eligibility

Inclusion criteria

Inclusion criteria: Patients of age group between 30 years and 70. Patients of either gender. (Females not on oestrogen therapy) Patients with HTN, DM and Obesity

Exclusion criteria

Exclusion criteria: Hyperlipidaemias due to 1.Genetic causes 2.Thyroid abnormalities 5.Alcohol abuse 4.familial hypercholesterolemia 5. Significant hepatic or renal function test abnormalities 6.Drug intake : Corticosteroids, Diuretics, Beta-blockers, Oral contraceptives, Cyclosporin, Androgens & Retinoids

Design outcomes

Primary

Measure	Time frame
Lipid profileTimepoint: 3 months	—

Secondary

Measure	Time frame
BMITimepoint: 90 days	—

Countries

India

Contacts

Public ContactHarinatha Chary

Parul Institute of Ayurveda

manu.r260022@paruluniversity.ac.in9481328130

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026